| |
(12 March 2012) Charles Bennett, endowed chair of the Center for Medication Safety and Efficacy, was cited in several national stories recently. He was interviewed by NationalPublic Radio to provide background on a national story about Tamiflu via theSouthern Network on Adverse Reactions (SONAR) network he founded. Earlier this year, he was cited in a national story on safety issues with a Bristol-Myers steroid. Bloomberg carried the story, which was reported in Business Week and other media. http://www.businessweek.com/news/2012-02-01/bristol-myers-warning-ignored-on-steroid-shots-tied-to-deaths.html. Bennett also was published in Archives of Internal Medicine with a memorable piece about his own cancer experience and his personal perspective on the current debate about PSA screening. http://archinte.ama-assn.org/cgi/reprint/172/4/311
|
